Pre-harvest gibberellic acid (GA(3)) treatments play an important role on bioactive compounds and fruit quality of sweet cherry cultivars


Özkan Y., Uçar M., Yıldız K., Öztürk B.

SCIENTIA HORTICULTURAE, cilt.211, ss.358-362, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 211
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.scienta.2016.09.019
  • Dergi Adı: SCIENTIA HORTICULTURAE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.358-362
  • Anahtar Kelimeler: Anthocyanin, Antioxidant, Color, Firmness, Fruit removal force, Phenolics, ANTIOXIDANT ACTIVITY, FIRMNESS, GROWTH, CAPACITY, CRACKING
  • Eskişehir Osmangazi Üniversitesi Adresli: Hayır

Özet

The effects of pre-harvest GA(3) treatments at different concentrations (0,30 and 60 mg L-1) on fruit quality attributes [geometric mean diameter, flesh firmness, hue angle, fruit removal force (FRF), soluble solids content (SSC) and titratable acidity] and bioactive compounds (total phenolics, total anthocyanin and total antioxidant capacity) of 0900 Ziraat, Regina and Sweetheart sweet cherry (Prunus avium L.) cultivars were investigated in 3 different harvest periods. GA(3)-treated Sweetheart fruits were significantly larger than the control fruits. Considering the hue angle values, it was observed that GA(3) treatments retarded red color development in all three cultivars. The loss in flesh firmness throughout the ripening period was significantly retarded with GA(3) treatments in all three cultivars. Fruit removal force was significantly higher in GA(3)-treated Regina and Sweetheart sweet cherries than in control fruits. The SSC values of GA(3)-treated fruits were generally lower than the control fruits. Total phenolics, total anthocyanin and total antioxidant capacity of GA(3)-treated fruits were also significantly lower than the control fruits. As compared to control treatment, total phenol content of Regina fruits with a week retarded harvest was 22 and 25% lower respectively in 30 and 60 mg L-1 GA(3) treatments. Similar results were observed. (C) 2016 Elsevier B.V. All rights reserved.